These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27264212)

  • 1. Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.
    Sawyer BT; LaFargue CJ; Bristow RE
    Gynecol Oncol; 2016 Aug; 142(2):378. PubMed ID: 27264212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
    Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical technique of en bloc pelvic resection for advanced ovarian cancer.
    Chang SJ; Bristow RE
    J Gynecol Oncol; 2015 Apr; 26(2):155. PubMed ID: 25872895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
    Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
    Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
    Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
    Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection.
    Hoffman MS; Tebes SJ; Sayer RA; Lockhart J
    Am J Obstet Gynecol; 2007 Aug; 197(2):209.e1-4; discussion 209.e4-5. PubMed ID: 17689654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
    Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA
    Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
    Khatib G; Guzel AB; Gulec UK; Vardar MA
    Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.
    Farias-Eisner R; Teng F; Oliveira M; Leuchter R; Karlan B; Lagasse LD; Berek JS
    Gynecol Oncol; 1994 Oct; 55(1):108-10. PubMed ID: 7959250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
    Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
    Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
    Gómez-Hidalgo NR; Martinez-Cannon BA; Nick AM; Lu KH; Sood AK; Coleman RL; Ramirez PT
    Gynecol Oncol; 2015 Jun; 137(3):553-8. PubMed ID: 25827290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colon resection for ovarian cancer: intraoperative decisions.
    Hoffman MS; Zervose E
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
    Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.
    Medina-Franco H; Cortés-González R; Lambreton-Hinojosa F; Fimbres-Morales A; Vargas-Siordia JC
    Ann Surg Oncol; 2017 May; 24(5):1330-1335. PubMed ID: 27995454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.